BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: Collectively, our preclinical results demonstrate that, although the committed CP-CML progenitors have been strongly sensitive to Venetoclax, CP-CML primitive leukemic cells do not dependent on BCL2 protein for their persistence.